GlassScriptPhysician profile
Kevin Mcgeagh
NPI 1154319549
$3,901.14
in general payments reported to CMS, 2019-2025
21 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,488 · 2020: $113 · 2021: $284 · 2022: $774 · 2023: $378 · 2024: $485 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,480.59 | 2019-2020 | |
| Procept Biorobotics Corporation | $533.58 | 2022 | |
| Dendreon Pharmaceuticals LLC | $251.05 | 2024-2025 | Provenge |
| Teleflex LLC | $245.90 | 2021-2022 | |
| Astellas Pharma US INC | $211.93 | 2019-2025 | Xtandi |
| Olympus America INC. | $163.79 | 2023-2025 | Itind System, Tecoflex |
| Axonics, INC. | $123.53 | 2022-2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $106.67 | 2019-2022 | |
| Abbvie INC. | $100.29 | 2021-2024 | |
| Urogen Pharma, INC. | $97.26 | 2023 | Jelmyto |
| Baxter Healthcare | $94.53 | 2024 | Tisseel |
| Immunitybio, INC. | $90.75 | 2025 | |
| Myovant Sciences INC. | $76.01 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $69.48 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $67.65 | 2023 | Titan |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $62.70 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $61.07 | 2022-2024 | Erleada |
| Sumitomo Pharma America, INC. | $20.60 | 2024 | Orgovyx |
| Urovant Sciences INC | $18.89 | 2021 | |
| Boston Scientific Corporation | $13.74 | 2019 | |
| Endo Pharmaceuticals INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mcgeagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.